<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>肿瘤资讯 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-25T20:17:34+08:00</updated>
  <subtitle>分享肿瘤领域最新进展，传播正确肿瘤防治理念，提高全社会对肿瘤的关注！新浪微博：@肿瘤资讯</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>对话大咖 | 张力教授：贝美纳（恩沙替尼）获批上市，填补ALK-TKI国产空白！</title>
    <updated>2020-11-25T19:14:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/XiYALtHjtCOBwehEUuEOGQ</id>
    <link href="https://mp.weixin.qq.com/s/XiYALtHjtCOBwehEUuEOGQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>《上皮性卵巢癌PARP抑制剂生物标志物检测中国专家共识》发布，吴小华教授解其中要义</title>
    <updated>2020-11-25T19:14:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/m5L01024gfPsT0ArXoAfGg</id>
    <link href="https://mp.weixin.qq.com/s/m5L01024gfPsT0ArXoAfGg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2020CCO】陈功教授专访：直肠癌治疗新趋势，更加重视功能保全</title>
    <updated>2020-11-25T19:14:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/1Q0HCV4Xjbe-6vPUcQjvXA</id>
    <link href="https://mp.weixin.qq.com/s/1Q0HCV4Xjbe-6vPUcQjvXA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>首届深莞惠消化道肿瘤高峰论坛暨深圳市消化道肿瘤MDT培训班圆满落幕</title>
    <updated>2020-11-25T19:14:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/v2gNNv1vWRtqVnIKgpyO2Q</id>
    <link href="https://mp.weixin.qq.com/s/v2gNNv1vWRtqVnIKgpyO2Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【悦谈 Vol.1】食管癌文献月评|食管癌二线免疫治疗获突破，围手术期治疗方案再优化</title>
    <updated>2020-11-25T19:14:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/W_GYHMW_yZcuHcMirpdMSA</id>
    <link href="https://mp.weixin.qq.com/s/W_GYHMW_yZcuHcMirpdMSA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【11月26日】中国消化道肿瘤免疫治疗学术论坛-2020 POST ESMO第十四场</title>
    <updated>2020-11-25T19:14:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/q1NhGiO9U5kw_5epxbuyrQ</id>
    <link href="https://mp.weixin.qq.com/s/q1NhGiO9U5kw_5epxbuyrQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【CCO 2020】马骏教授：鼻咽癌治疗中国经验改变国际指南，未来仍需探索</title>
    <updated>2020-11-24T18:57:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/KyU3rwy5Cd8w_PXVSxYlzg</id>
    <link href="https://mp.weixin.qq.com/s/KyU3rwy5Cd8w_PXVSxYlzg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020 ESMO ASIA︱恩沃利单抗治疗MSI-H/dMMR晚期实体瘤展现非凡实力</title>
    <updated>2020-11-24T18:57:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/WoutsyrD-VrXE_OAvJUbSQ</id>
    <link href="https://mp.weixin.qq.com/s/WoutsyrD-VrXE_OAvJUbSQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【CCO 2020】吴小华教授：子宫内膜癌分子分型逐渐走向临床</title>
    <updated>2020-11-24T18:57:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/uK4PmLXFxrMU977c6TxyNA</id>
    <link href="https://mp.weixin.qq.com/s/uK4PmLXFxrMU977c6TxyNA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>梁寒教授：GIST精准治疗前沿进展与展望</title>
    <updated>2020-11-24T18:57:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/eaobh-0rI9RaTqx_tfBAZw</id>
    <link href="https://mp.weixin.qq.com/s/eaobh-0rI9RaTqx_tfBAZw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>经典回顾：抗EGFR单抗在R/M SCCHN 的一线治疗探索</title>
    <updated>2020-11-24T18:57:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/viNBwYJMsHkYxf87qaodRg</id>
    <link href="https://mp.weixin.qq.com/s/viNBwYJMsHkYxf87qaodRg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【ESMO ASIA】束永前教授&amp;李相成教授团队研究获壁报展示，信迪利单抗联合安罗替尼用于晚期HCC一线治疗前景可期</title>
    <updated>2020-11-24T18:57:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/DdQAJZ_CxY7EmJicf_vt5A</id>
    <link href="https://mp.weixin.qq.com/s/DdQAJZ_CxY7EmJicf_vt5A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>王燕教授深入解读CheckMate 078和CheckMate 870研究，优化驱动基因阴性晚期NSCLC二线治疗策略</title>
    <updated>2020-11-24T18:57:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/mRMagR7HfMMQVmSgU2-lNw</id>
    <link href="https://mp.weixin.qq.com/s/mRMagR7HfMMQVmSgU2-lNw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【ESMO Asia】顾艳宏教授&amp;骆金华教授团队研究：信迪利单抗联合化疗打造全新治疗模式，或解食管癌新辅助治疗难题</title>
    <updated>2020-11-24T18:57:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/q8Ldh7COu5kXMLNQXzNnsQ</id>
    <link href="https://mp.weixin.qq.com/s/q8Ldh7COu5kXMLNQXzNnsQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020 ESMO ASIA 肝癌中国之声 | 信迪利单抗联合贝伐珠单抗高歌猛进，或为晚期肝癌一线治疗贡献中国方案</title>
    <updated>2020-11-23T20:00:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/V0QShwWPxTn6OrG2A3HHiQ</id>
    <link href="https://mp.weixin.qq.com/s/V0QShwWPxTn6OrG2A3HHiQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>山东省抗癌协会肺癌分会第十一届学术年会成功举办，新时代下新发展，RET融合NSCLC治疗迎来新突破</title>
    <updated>2020-11-23T20:00:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/Gx9PSYeC0JX8b6ytzvflKw</id>
    <link href="https://mp.weixin.qq.com/s/Gx9PSYeC0JX8b6ytzvflKw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>敢为人先，中国首个“免疫联合化疗治疗经治晚期NSCLC研究”亮相ESMO Asia</title>
    <updated>2020-11-23T20:00:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/pUtNL1j89aHq3gY-v4N5mA</id>
    <link href="https://mp.weixin.qq.com/s/pUtNL1j89aHq3gY-v4N5mA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020 CCO|曹洋教授：中医药联合免疫治疗，传统与现代的激情碰撞</title>
    <updated>2020-11-23T20:00:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/lJZo_jCirqv-dXfLksCJ_w</id>
    <link href="https://mp.weixin.qq.com/s/lJZo_jCirqv-dXfLksCJ_w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【CDK4/6i学院】叶松青教授：HR+/HER2-晚期乳腺癌内分泌敏感人群一线治疗选择？重要研究深入解读</title>
    <updated>2020-11-23T20:00:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/Qn4kO3F92oobjcBiNbsj9w</id>
    <link href="https://mp.weixin.qq.com/s/Qn4kO3F92oobjcBiNbsj9w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>风骨多美，声势加素丨2020年CSCO骨肉瘤指南系列巡讲·贵州站隆重开启</title>
    <updated>2020-11-23T20:00:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/LZzMiN-2LOk-w3qgf8pdJA</id>
    <link href="https://mp.weixin.qq.com/s/LZzMiN-2LOk-w3qgf8pdJA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>